After a tumultuous period of bankruptcy and closures, TGI Fridays CEO Ray Blanchette is steering a deeply personal turnaround. Early results from holiday pop-ups and a revamped brand voice show promise, but the road to 1,000 restaurants remains steep.
Opera's stock surged following the announcement of expanded Tether (USDT and XAUT) integration in its MiniPay wallet, which processed over $153M in stablecoin transactions in December and aims to simplify crypto access for its 12.6 million users in emerging economies.
Clinical-stage biotech Erasca (ERAS) has seen its stock skyrocket over the past 12 months, hitting a multi-year high. While technical momentum is strong, the company remains pre-revenue, with its fate tied to future drug approvals, presenting a classic high-risk, high-reward scenario for investors.
The Hennepin County Medical Examiner has officially classified the January shooting death of ICU nurse Alex Pretti as a homicide, a finding that intensifies legal and public pressure on the federal agents involved amid ongoing protests and disputed official narratives.
A high-earning Orlando software engineer faces a stark choice: pursue a lifelong dream in federal law enforcement at a major pay cut and a significant real estate loss, or stay put in a lucrative tech career. His story highlights the personal costs behind shifting housing markets and career pivots.
Shares of PlayStudios fell sharply amid a broad gaming stock sell-off triggered by Google's unveiling of a real-time 3D world-generating AI, raising fears of industry disruption.
Terex Corporation shares gained over 4% following the finalization of its merger with REV Group, creating a diversified specialty equipment giant. The deal is projected to yield $75 million in annual synergies by 2028.
WK Kellogg Co. names former Ferrero executive Jean-Baptiste Santoul as Chief Operating Officer, signaling a strategic shift following its $3.1 billion acquisition by the global confectionery giant.
The medical device developer Beta Bionics has received a warning letter from the U.S. Food and Drug Administration, a regulatory action stemming from a facility inspection last summer. The company maintains the letter will not disrupt its operations, manufacturing, or the planned launch of its new insulin patch pump.
In a strategic reshuffle following the exit of its product chief, Netflix has merged its product and technology divisions under veteran executive Elizabeth Stone, signaling a tighter integration of engineering and user experience.
A significant reset in analyst price targets for iRhythm Holdings (IRTC) is prompting investors to reassess the cardiac monitoring firm's risk-reward profile. This shift reflects evolving views on reimbursement headwinds, competitive pressures, and long-term growth catalysts in the digital health sector.
Abbott Laboratories moves to acquire cancer-testing leader Exact Sciences in a landmark deal, signaling a strategic shift toward high-growth diagnostics while simultaneously restructuring its challenged Nutrition business.
Novo Nordisk launches its first oral GLP-1 weight-loss drug with strong early demand, reports positive Phase 3 results for CagriSema, and expands a cell therapy partnership for diabetes. These moves come as investors reevaluate the company's long-term growth prospects amid competitive and pricing pressures.
CNBC's Jim Cramer expressed renewed bullishness on Tesla, shifting focus from its electric vehicle business to its ambitions in robotics and autonomous 'Cybercab' technology following the company's latest earnings call.
EPAM Systems' stock has surged over 30% in three months, riding a wave of AI optimism. Yet, this rebound contrasts sharply with longer-term declines, leaving investors to weigh if the current price fully reflects future growth or overlooks persistent risks in the IT services sector.
BioNTech's stock faces pressure following a Leerink Partners downgrade, which tempered near-term optimism around its oncology pipeline after a recent rally. The move highlights investor reassessment of catalysts amid mixed long-term performance.
As BHP Group advances plans to create one of the world's first fully autonomous copper mines at Escondida Norte, it simultaneously contends with Chinese import restrictions on its Jimblebar iron ore and ramps up exploration via its 2026 Xplor program, highlighting the complex balancing act facing the global mining giant.
Despite both tech giants aggressively investing in AI, their stock prices are telling divergent stories. We examine the underlying fundamentals that make them resilient picks for any portfolio, regardless of short-term volatility.
Ukraine's defense minister confirms collaborative efforts with SpaceX have yielded initial success in countering Russia's unauthorized use of Starlink terminals to guide attack drones, with a new verification system imminent.
Arabica futures edge higher on technical moves, while robusta prices tumble as favorable weather in Brazil and surging Vietnamese exports point to ample supplies, pressuring the market.
